Company Profile
Perrigo Company PLC Stock Price, News & Analysis
Company overview
Business overview
PRGO is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, PRGO is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
PRGO follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, PRGO sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Why the stock is moving
PRGO is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Future catalysts
Perrigo's story is mostly operational and portfolio-driven, with Project Energize and the Dermacosmetics divestiture doing most of the work. The question is whether the business can keep simplifying itself while still extracting value from the self-care and consumer health franchises.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Perrigo to Present at the UBS Global Consumer and Retail Conference
Source: Perrigo Company PLC
- 02
- 03
- 04
Perrigo Announces Quarterly Dividend
Source: PRGO
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.